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Surgical treatment of a primary tracheal angiosarcoma
Jin-Shing Chen, MD,a Yih-Leong Chang, MD,b Hsao-Shun Shu, MD,a and Yung-Chie Lee, MD, PhD,a Taipei, Taiwan
Angiosarcomas of the pulmonary system are extremely rare and usually representmetastatic diseases.1 Only one case of primary tracheal angiosarcoma has beenreported after autopsy.2 The pathogenesis of primary pulmonary angiosarcomaand the association with chemicals are not confirmed. No successful treatment of
primary tracheal angiosarcoma has been reported, and the prognosis of this rare disease after
surgical resection is unknown. We report a case of a patient with primary tracheal angiosar-
coma with an 18-year history of occupational exposure to aerosols of paint pigments. The
distinct clinical features of repeated hemoptysis caused by a single, small fleshy tumor at the
lower end of the trachea and successful treatment by means of surgical intervention are
believed to be the first of their kind.
Clinical Summary
A 44-year-old Chinese man was admitted to another hospital because of repeated hemoptysis
for 3 months. He was a nonsmoker. He had been working as a spray painter, using a
pneumatic spray gun, for 18 years in an environment filled with aerosols of paint pigments.
Physical examination revealed a well-developed and well-nourished man in no apparent
distress. Routine laboratory investigations and electrocardiograms showed no remarkable
findings. The lungs were clear on the basis of chest radiography. At bronchoscopic exami-
nation, a 7-mm red fleshy nodule with blood coating and easy-touch bleeding was identified
at the right membrane-cartilage junction of the lower trachea, about 1 cm above the level of
the carina (Figure 1). Transbronchial biopsy revealed a poorly differentiated carcinoma or
sarcoma-like tumor. The diagnosis was not confirmed because of having an inadequate
specimen. He was transferred to our hospital for further management.
Bronchoscopic examination repeated at our hospital disclosed that the tumor was slightly
flatter and smaller after biopsy. Chest computed tomographic scanning showed clear lung
fields with no mediastinal lymphadenopathy. Ultrasonographic examination of the heart,
whole-body bone scanning, and computed tomographic scanning of the head and abdomen
failed to disclose any tumor in other locations. The patient underwent a right standard
thoracotomy through the fourth intercostal space. After circumferential mobilization of the
lower trachea and both main bronchi, the involved trachea was segmentally resected, with
resection margins of 1 cm in both the upper and lower directions. No obvious lymphade-
nopathy was noted in the surrounding mediastinum. Both ends of the trachea were then
anastomosed with interrupted sutures.
On microscopic examination, the tumor had eroded the tracheal wall through the cartilage
with mostly denuded mucosa. The resection margins were free of tumor. Sections of the
tumor demonstrated sheets of highly pleomorphic malignant endothelial cells filling thin-
walled vascular channels and exhibiting prominent mitotic activity (Figure 2). Immunohis-
tochemically, the tumor cells were positively stained for vimentin diffusely and for CD31
(Figure 3) and CD34 focally. The factor VIII–related antigen, cytokeratin, S-100 protein, and
smooth muscle actin staining results were all negative. After the operation, 3 stitches were
placed between the chin and chest to hold the patient’s head in flexion. The stitches were cut
on the seventh postoperative day. The postoperative course was uneventful. The patient has
been followed up for 12 months without any evidence of recurrence.
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Discussion
The presence of angiosarcoma in the pulmonary system is usually
a consequence of metastasis from a primary site in the skin, breast,
liver, bone, spleen, or heart.1 Primary angiosarcomas of the pul-
monary system are extremely rare, with no more than 20 cases in
the medical literature.1-4 Most of these tumors are multiple, arising
in the periphery of pulmonary parenchymal tissue with bilateral
involvement, thereby making the question of primary location
uncertain. Only 2 patients were reported with a solitary nodule in
the main airway. One was an 81-year-old man with a tumor of 20
mm in the lower trachea near the takeoff of the right main bron-
chus, almost in the same position as for this patient.2 The other was
a 59-year-old man with a tumor of 15 mm in the right upper
bronchus.3 Both patients died as a result of massive and intractable
hemoptysis caused by the tumor. No definite diagnosis or effective
treatment could be made before the patients’ deaths.
Factors contributing to the development of primary pulmonary
angiosarcoma are unclear. Although exposure to heavy metals,
such as arsenic, in paint pigments is associated with the pathogen-
esis of hepatic angiosarcoma,5 this relationship has not been es-
tablished in primary pulmonary angiosarcoma. Only one patient
with a history of industrial exposure in copper mines has been
reported.1 This patient is a spray painter, and 18 years of occupa-
tional exposure to paint-pigment aerosols containing heavy metals
seems to be a possible risk factor in the development of this kind
of tumor. However, the association between the tracheal angiosar-
coma and paint pigments is almost impossible to determine be-
cause of a long latent period and the rarity of the disease. Never-
theless, the question of toxic exposure with the development of a
related malignancy must be raised.
Previous reports indicate that preoperative diagnosis of primary
angiosarcoma of the main airway was not made,2,4 as occurred in
this patient. Hemorrhagic diathesis of the tumor, inadequate biopsy
of bronchoscopic examination, and the rarity of the disease make
definite diagnosis almost impossible. Even after the operation or
on the basis of postmortem examination, the diagnosis of neo-
plasms of the blood vessels also presents many difficulties in
distinction between benign and malignant, as well as primary and
secondary, lesions.
Stout’s diagnostic criteria of angiosarcoma include the forma-
tion of atypical endothelial cells in greater numbers than are
required to line the vessels with a simple endothelial membrane
and the formation of vascular tubes with a delicate network of
reticulin fibers and a marked tendency for their lumens to anasto-
mose.6 The findings in this case are consistent with these criteria.
The other diagnostic consideration in this patient is poorly differ-
entiated carcinoma.7 The positive immunohistochemical staining
of the neoplasm with vimentin, CD31, and CD34 supports the
endothelial origin of the tumor in our patient and also helps correct
the diagnosis in ambiguous cases. Staining for the factor VIII–
related antigen was negative in this patient, but this is not uncom-
mon in very anaplastic tumors of endothelial origin.1 Moreover,
negative staining for cytokeratin, S-100 protein, and smooth mus-
cle actin confirms that the neoplasm is not of epithelial, neuro-
genic, or myogenic origin.
Figure 1. At bronchoscopy, a 7-mm red fleshy nodule was noted at
the lower trachea near the takeoff of the right main bronchus.
Figure 2. Angiosarcoma composed of highly pleomorphic tumor
cells with rudimentary lumen formation. (Hematoxylin and eosin,
original magnification 66.)
Figure 3. Immunostaining for CD31 shows intense staining of
some angiosarcoma cells. (ABC method, original magnification
132.)
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The prognosis of primary angiosarcoma of the pulmonary
system is generally poor, irrespective of whether the location is in
the pulmonary parenchyma or the main airway. Angiosarcoma of
the pulmonary parenchyma is invariably fatal within months be-
cause metastases are usually present at the time of detection, and
chemotherapy thus far has not proved effective. The clinical course
of solitary angiosarcoma of the main airway is also dismal in
previous reports.2,4 However, mortality of these patients was
mainly caused by massive and intractable hemoptysis of the small
resectable tumor rather than by the invasiveness of the disease.
From the experience of successful treatment of this patient, angio-
sarcoma should be considered in the differential diagnosis of a
primary tracheal tumor. Furthermore, prompt surgical intervention
with adequate resection margins is recommended in the manage-
ment of these patients when the disease is localized at detection.
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Primary choriocarcinoma of the lung
Anna Arslanian, MD,a Franco Pischedda, MD,a Pier Luigi Filosso, MD,a Paolo Di Marzio, MD,a Alberto Oliaro, MD,a
Flavio Fraire, MD,b and Mauro Papotti, MD,b Torino, Italy
Choriocarcinoma is a malignant proliferation of theLangerhans cell and of syncytial cells of trophoblasticorigin that is normally situated in the female genitaltract after a gestational event such as molar pregnancy,
term pregnancy, abortion, or ectopic pregnancy.1 Rarely it occurs
in either sex as a midline lesion in the retroperitoneum, mediasti-
num, and the region of the pineal gland. Less frequently it is found
in the bladder, liver, stomach, and colon, where it is seen in
combination with adenocarcinoma.2-4 In men, choriocarcinoma
occurs in the testis in combination with such tumors as seminoma,
teratoma, and embryonal carcinoma.1 The literature contains few
cases of lung localization of choriocarcinoma. The prognosis of
this tumor is extremely poor, despite surgical and chemotherapeu-
tic treatment.5 We report a surgically treated case of choriocarci-
noma in a 37-year-old woman who came to our attention because
of a lung tumor with radiologic characteristics similar to those of
a solitary fibrous tumor of the pleura.
Clinical Summary
During surgical evaluation for cholecystectomy for cholelithiasis
in a 37-year-old woman, the chest radiograph showed an opacity in
the right inferior pulmonary lobe (Figure 1). Computed tomo-
graphic scans demonstrated a well-demarcated mass similar to
solitary fibrous tumor of the pleura (Figure 2). On physical exam-
ination, the woman appeared healthy with stable vital signs. The
patient referred in her history to an operation for vesicular mole
that had occurred 7 years previously.
A needle biopsy was performed, and the result of cytologic
examination of the cells was compatible with the hypothesis of
fibrous tumor. A right thoracotomy was performed. The lung
appeared to be infiltrated by a tumor not compatible with the
hypothesis of a solitary fibrous tumor of the pleura. An inferior
lobectomy was performed. The postoperative recovery was un-
eventful, and the patient was discharged in 8 postoperative days. A
definitive histologic examination demonstrated a choriocarcinoma
(Figure 3, a-e). -Human chorionic gonadotropin (-HCG) was
measured in the serum at that time, and the level was high (597
IU/L, whereas the normal level is 0-10 IU/L).
Computed tomographic scan of the ovary and the genital ap-
paratus was performed to research a possible primary localization,
but nothing was found. Hysteroscopy was also performed, and
results were negative. The previous specimen of the vesicular mole
was reexamined, but no cells of choriocarcinoma were found.
Chemotherapy was started 2 months after thoracic surgery and
consisted of bleomycin, etoposide, and cisplatin. Before the start of
chemotherapy, the level of -HCG was measured; it was 8 U/L 40
days after surgery. At 1-year follow-up the patient is alive in good
condition. The -HCG level is actually normal.
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